Century(300078)
Search documents
思创智联:公司产品覆盖EAS标签、RFID inlay、特种标签、读写设备及应用软件
Zheng Quan Ri Bao Zhi Sheng· 2026-02-09 09:41
证券日报网讯 2月9日,思创智联在互动平台回答投资者提问时表示,公司作为拥有二十余年物联网技 术研发与产业应用经验的企业,现已构建从天线设计、标签封装到系统集成的完整产业链,产品覆盖 EAS标签、RFIDinlay、特种标签、读写设备及应用软件,远销全球70多个国家和地区。公司已于近日 完成公司名称、证券简称的变更,未来公司将聚焦RFID电子标签、EAS防盗标签智能制造业务发展战 略,以苍南县、扬州市、杭州市为公司核心物联智能制造基地,公司经营重心将全面回归智能制造主 业。 (编辑 袁冠琳) ...
思创智联:公司已在定期报告中披露对应时点的股东人数
Zheng Quan Ri Bao Wang· 2026-02-09 09:12
证券日报网讯2月9日,思创智联(300078)在互动平台回答投资者提问时表示,公司已在定期报告中披 露对应时点的股东人数。 ...
思创智联:预计2025年净利润亏损4124.57万元至8249.15万元
Jing Ji Guan Cha Wang· 2026-01-26 11:08
经济观察网2026年1月26日,思创智联(300078)发布2025年度业绩预告,预计2025年净利润亏损 4124.57万元至8249.15万元。扣除非经常性损益后的净利润亏损1.18亿元至2.19亿元。 ...
思创智联:2025年预亏4124.57万元~8249.15万元 同比减亏
Mei Ri Jing Ji Xin Wen· 2026-01-26 08:21
每经AI快讯,思创智联(300078)1月26日发布2025年度业绩预告,预计2025年归母净利润亏损4124.57 万元~8249.15万元,同比减亏,上年同期亏损1亿元。报告期内公司将智慧医疗板块业务子公司医惠科 技100%股权出售给苍南县山海数字科技有限公司,于2025年8月完成交割,不再持有医惠科技股权,医 惠科技不再纳入公司合并报表范围。此次交易将经营状况不佳的资产从公司剥离,旨在提升公司盈利能 力,实现业务结构优化和转型升级。 ...
思创智联(300078.SZ):预计2025年亏损4124.57万元—8249.15万元
Ge Long Hui A P P· 2026-01-26 08:14
2、公司根据投资标的业务发展趋势,基于谨慎性原则,对投资标的进行了评估和减值测试,计提资产 减值准备及公允价值损失。最终计提数据将由公司聘请的专业评估机构及审计机构进行评估和审计后确 定。3、本报告期内,公司预计归属于上市公司股东的非经常性损益金额约为8,000万元至13,000万元, 主要系公司完成重大资产重组,将持有的子公司医惠科技100%股权对外出售产生的投资收益,最终金 额将由公司聘请的审计机构进行审计后确定。 格隆汇1月26日丨思创智联(维权)(300078.SZ)公布,预计2025年亏损4,124.57万元—8,249.15万元,上 年同期重组后亏损10,023.41万元;扣非亏损11,801.28万元—21,925.85万元。1、报告期内,公司将智慧 医疗板块业务子公司医惠科技100%股权出售给苍南县山海数字科技有限公司,并于2025年8月完成交 割,交易完成后,公司不再持有医惠科技股权,医惠科技不再纳入公司合并报表范围。近年来,公司智 慧医疗业务受行业竞争激烈、业务调整等多方面因素影响导致持续亏损,对公司的整体经营发展造成了 较大不利影响。本次交易将经营状况不佳的资产从公司剥离,旨在提升公司盈 ...
思创智联发预亏,预计2025年度归母净亏损4124.57万元—8249.15万元
Zhi Tong Cai Jing· 2026-01-26 07:56
思创智联(300078)(300078.SZ)披露2025年度业绩预告,公司预计归属于上市公司股东的净亏损 4124.57万元—8249.15万元;扣除非经常性损益后的净亏损1.18亿元至2.19亿元。 报告期内,公司将智慧医疗板块业务子公司医惠科技100%股权出售给苍南县山海数字科技有限公司, 并于2025年8月完成交割,交易完成后,公司不再持有医惠科技股权,医惠科技不再纳入公司合并报表 范围。近年来,公司智慧医疗业务受行业竞争激烈、业务调整等多方面因素影响导致持续亏损,对公司 的整体经营发展造成了较大不利影响。本次交易将经营状况不佳的资产从公司剥离,旨在提升公司盈利 能力,实现业务结构优化和转型升级。 ...
思创智联(300078.SZ)发预亏,预计2025年度归母净亏损4124.57万元—8249.15万元
智通财经网· 2026-01-26 07:55
报告期内,公司将智慧医疗板块业务子公司医惠科技100%股权出售给苍南县山海数字科技有限公司, 并于2025年8月完成交割,交易完成后,公司不再持有医惠科技股权,医惠科技不再纳入公司合并报表 范围。近年来,公司智慧医疗业务受行业竞争激烈、业务调整等多方面因素影响导致持续亏损,对公司 的整体经营发展造成了较大不利影响。本次交易将经营状况不佳的资产从公司剥离,旨在提升公司盈利 能力,实现业务结构优化和转型升级。 思创智联(300078.SZ)披露2025年度业绩预告,公司预计归属于上市公司股东的净亏损4124.57万元— 8249.15万元;扣除非经常性损益后的净亏损1.18亿元至2.19亿元。 ...
思创智联(300078) - 2025 Q4 - 年度业绩预告
2026-01-26 07:42
证券代码:300078 证券简称:思创智联 公告编号:2026-005 思创智联科技股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 预计的业绩:预计净利润为负值。 | 目 | | 本报告期 | 上年同期 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 项 | | | 重组前 | 重组后 | | | | | 归属于上市公司 股东的净利润 | 亏损:4,124.57 | 万元—8,249.15 万元 | 亏损:50,150.98 | | 万元 | 亏损:10,023.41 | 万元 | | 扣除非经常性损 益后的净利润 | 亏损:11,801.28 | 万元—21,925.85 | 万元 亏损:44,156.90 | | 万元 | 亏损:5,254.36 | 万元 | 注 1:以上表格中的"万元"均指人民币万元。 注 2:本报告期内,思创智联科技股份有限公司(以下简称"公司")已完 成重大资产重组,将持有的子公司医惠科技有限公司(以下简称"医惠科技") ...
RFID核心上市公司分析
Xin Lang Cai Jing· 2026-01-19 13:16
Industry Overview - RFID (Radio Frequency Identification) is experiencing a golden development period driven by both scenario expansion and technological upgrades, with a global market size expected to exceed 160 billion yuan by 2025, maintaining an annual growth rate of over 14%, and China's market growing even faster at over 20% [1][2] - The core bottleneck is the insufficient supply of specialized chips, with a domestic high-end chip localization rate of only 40%, and ultra-high frequency tag chips still reliant on imports [1][2] - The competitive landscape is intensifying, with AI empowerment becoming a key differentiator; leading companies are building barriers through vertical integration and technological innovation [1][2] Core Listed Companies Analysis 1. **$Yuan Wang Gu (002161) - RFID Absolute Leader** - Core advantage: The first RFID listed company in China, with over 50% market share in railway vehicle number recognition systems and deep layouts in retail, library, and logistics sectors [1][2] - Latest development: Plans to raise 691 million yuan for RFID production lines, chip process upgrades, and AIoT innovation centers, enhancing capabilities in large storage, encryption, high sensitivity, and wide temperature range chips [1][2] - Financial performance: Expected gross margin of 41.51% in 2024 (up 2.17 percentage points year-on-year), with a low net margin and still in loss after deducting non-recurring items; AI integration is anticipated to unlock value reassessment [3][4] 2. **$Fudan Microelectronics (688385) - Chip Design Leader** - Core advantage: Leading in RFID chip design in China, with rapid growth in security and identification chip businesses; antenna etching process reduces PET substrate waste below industry average [3][4] - Market position: Competing with international giants in the ultra-high frequency tag chip market, with product performance close to brands like NXP [3][4] - Technical highlights: Chip process transitioning from 90nm to 65nm, with power consumption reduced by over 40% and storage capacity increased by 50% [3][4] 3. **$Sichuan Medical (300078) - Smart Medical Segment Leader** - Core advantage: Leading in medical RFID solutions, embedding electronic tags in medical consumables and smart shelves, serving international clients like ZARA [3][4] - Growth logic: Accelerated medical informationization and smart hospital construction are driving the implementation of high-value RFID application scenarios [3][4] 4. **Other Key Enterprises** - **Dongxin Peace (002017)**: Focused on smart cards/RFID tags with a production capacity of 1.5 billion pieces, strong advantages in ticket management and anti-counterfeiting traceability [3][4] - **Aerospace Information (600271)**: Engaged in tax informationization and RFID, holding a 5.8% market share in ticket management with a vertically integrated layout [3][4] - **Xiamen Xinda (000701)**: Involved in RFID and supply chain, with a stock price increase of 5.9% in the last 30 days and a 1.66% rise since 2026 [3][4] Investment Logic and Key Insights 1. **Four Major Investment Themes** - **Chip Localization**: Shortage of specialized chips, supported by policies and technological breakthroughs driving import substitution, benefiting companies like Fudan Microelectronics and Yuan Wang Gu [2][3] - **AIoT Integration**: AI empowerment enhances RFID data processing capabilities, benefiting Yuan Wang Gu (AI innovation center) and Sichuan Medical [2][3] - **Scenario Expansion**: Retail digitalization, Industry 4.0, and smart medical needs are expected to explode, benefiting Yuan Wang Gu, Sichuan Medical, and Dongxin Peace [2][3] - **Vertical Integration**: Full industry chain layout reduces costs and enhances risk resistance, benefiting Yuan Wang Gu and Aerospace Information [2][3] 2. **Key Technical Breakthroughs** - Core function upgrades include large storage capacity (to address data volume surges), data encryption (for privacy protection), high sensitivity (to improve recognition accuracy), and wide temperature range operation (to adapt to industrial/outdoor scenarios) [2][3] - Cost reduction path: Scale production has reduced the unit cost of UHF tags to 0.21-0.25 yuan, which is 30% lower than the industry average [2][3] - AI integration direction: Combining RFID data with machine learning to achieve smart inventory management and predictive maintenance, among other value-added services [4] Focused Analysis - Yuan Wang Gu stands out as the industry leader with benefits from capital increase, expansion, and AI empowerment, with stable cash flow from the railway market supporting transformation and growth opportunities in consumer IoT [4] - Fudan Microelectronics showcases strong chip design capabilities, benefiting from domestic substitution; Sichuan Medical operates in a high-growth medical niche with significant earnings elasticity [4] - Configuration strategy: Short-term focus on the progress of capital increase and AI project advancement; long-term layout on the dual dividends of scenario expansion and chip localization, while avoiding low-value enterprises engaged in pure price competition [4]
思创医惠(300078.SZ):1月20日起证券简称变更为“思创智联”
Ge Long Hui A P P· 2026-01-19 12:29
格隆汇1月19日丨思创医惠(300078.SZ)公布,本次公司变更证券简称事项已经深圳证券交易所审核无异 议,自2026年1月20日起,公司证券简称由"思创医惠"变更为"思创智联(维权)",证券代 码"300078"保持不变。 ...